Nippon India Pharma Fund-Growth Plan-Growth Option

NAV: as on:
MIn SIP Amount: 100
Rating: Not Rated
Fund Size: 8139.5664
SIP Amount
Frequency
SIP Start Date
Holdings
Name Sector Instrument Type Assets(%)
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 13.85
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 13.85
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 13.85
Divi'S Laboratories Ltd Pharmaceuticals -- 8.17
Divi'S Laboratories Ltd Pharmaceuticals -- 8.17
Divi'S Laboratories Ltd Pharmaceuticals -- 8.17
Lupin Ltd Pharmaceuticals -- 7.52
Lupin Ltd Pharmaceuticals -- 7.52
Lupin Ltd Pharmaceuticals -- 7.52
Cipla Ltd Pharmaceuticals -- 5.88
Cipla Ltd Pharmaceuticals -- 5.88
Cipla Ltd Pharmaceuticals -- 5.88
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 5.81
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 5.81
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 5.81
Apollo Hospitals Enterprises Ltd Health Care -- 5.27
Apollo Hospitals Enterprises Ltd Health Care -- 5.27
Apollo Hospitals Enterprises Ltd Health Care -- 5.27
Zydus Lifesciences Ltd Pharmaceuticals -- 4.14
Zydus Lifesciences Ltd Pharmaceuticals -- 4.14
Zydus Lifesciences Ltd Pharmaceuticals -- 4.14
Gland Pharma Ltd Pharmaceuticals -- 3.95
Gland Pharma Ltd Pharmaceuticals -- 3.95
Gland Pharma Ltd Pharmaceuticals -- 3.95
Ajanta Pharma Ltd Pharmaceuticals -- 3.18
Ajanta Pharma Ltd Pharmaceuticals -- 3.18
Ajanta Pharma Ltd Pharmaceuticals -- 3.18
Aurobindo Pharma Ltd Pharmaceuticals -- 3.17
Aurobindo Pharma Ltd Pharmaceuticals -- 3.17
Aurobindo Pharma Ltd Pharmaceuticals -- 3.17
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 3.02
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 3.02
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 3.02
Abbott India Ltd Pharmaceuticals -- 3.01
Abbott India Ltd Pharmaceuticals -- 3.01
Abbott India Ltd Pharmaceuticals -- 3.01
Vijaya Diagnostic Centre Ltd Health Care -- 2.94
Vijaya Diagnostic Centre Ltd Health Care -- 2.94
Vijaya Diagnostic Centre Ltd Health Care -- 2.94
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals -- 2.79
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals -- 2.79
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals -- 2.79
Medplus Health Services Ltd Retailing -- 2.57
Medplus Health Services Ltd Retailing -- 2.57
Medplus Health Services Ltd Retailing -- 2.57
Narayana Hrudayalaya Ltd Health Care -- 2.32
Narayana Hrudayalaya Ltd Health Care -- 2.32
Narayana Hrudayalaya Ltd Health Care -- 2.32
Mankind Pharma Ltd Pharmaceuticals -- 2.24
Mankind Pharma Ltd Pharmaceuticals -- 2.24
Mankind Pharma Ltd Pharmaceuticals -- 2.24
Pfizer Ltd Pharmaceuticals -- 2.21
Pfizer Ltd Pharmaceuticals -- 2.21
Pfizer Ltd Pharmaceuticals -- 2.21
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 1.96
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 1.96
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 1.96
Sanofi India Ltd Pharmaceuticals -- 1.87
Sanofi India Ltd Pharmaceuticals -- 1.87
Sanofi India Ltd Pharmaceuticals -- 1.87
Alkem Laboratories Ltd Pharmaceuticals -- 1.81
Alkem Laboratories Ltd Pharmaceuticals -- 1.81
Alkem Laboratories Ltd Pharmaceuticals -- 1.81
Thyrocare Technologies Ltd Health Care -- 1.77
Thyrocare Technologies Ltd Health Care -- 1.77
Thyrocare Technologies Ltd Health Care -- 1.77
Fortis Healthcare Ltd Health Care -- 1.73
Fortis Healthcare Ltd Health Care -- 1.73
Fortis Healthcare Ltd Health Care -- 1.73
Dr. Lal Pathlabs Ltd Health Care -- 1.61
Dr. Lal Pathlabs Ltd Health Care -- 1.61
Dr. Lal Pathlabs Ltd Health Care -- 1.61
Triparty Repo Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.51
Triparty Repo Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.51
Triparty Repo Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.51
Syngene International Ltd Health Care -- 1.12
Syngene International Ltd Health Care -- 1.12
Syngene International Ltd Health Care -- 1.12
Orchid Pharma Ltd Pharmaceuticals -- 1.07
Orchid Pharma Ltd Pharmaceuticals -- 1.07
Orchid Pharma Ltd Pharmaceuticals -- 1.07
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.99
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.99
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.99
Indoco Remedies Ltd Pharmaceuticals -- 0.75
Indoco Remedies Ltd Pharmaceuticals -- 0.75
Indoco Remedies Ltd Pharmaceuticals -- 0.75
Astrazeneca Pharma India Ltd Pharmaceuticals -- 0.55
Astrazeneca Pharma India Ltd Pharmaceuticals -- 0.55
Astrazeneca Pharma India Ltd Pharmaceuticals -- 0.55
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 0.48
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 0.48
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 0.48
Healthcare Global Enterprises Ltd Health Care -- 0.39
Healthcare Global Enterprises Ltd Health Care -- 0.39
Healthcare Global Enterprises Ltd Health Care -- 0.39
Concord Biotech Ltd Pharmaceuticals -- 0.3
Concord Biotech Ltd Pharmaceuticals -- 0.3
Concord Biotech Ltd Pharmaceuticals -- 0.3
Cash/Bank/Net Current Assets/(Liabilities) Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.04
Cash/Bank/Net Current Assets/(Liabilities) Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.04
Cash/Bank/Net Current Assets/(Liabilities) Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.04
Cash Margin - CCIL Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.01
Cash Margin - CCIL Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.01
Cash Margin - CCIL Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.01
Holding analysis
Asset Class Percentage
Equity 98.4586
Debt 0
Cash
Equity sector allocation
Pharmaceuticals
Health Care
Retailing
Cash/Deposits/Margins/Treps/Repo/Swaps
Pharmaceuticals & Biotechnology
233.19
51.45
7.71
4.68
2.97
Sector Holding Percentage
Pharmaceuticals 233.19
Health Care 51.45
Retailing 7.71
Cash/Deposits/Margins/Treps/Repo/Swaps 4.68
Pharmaceuticals & Biotechnology 2.97
Advanced Ratios
Standard Dev. 11.983
P/E Ratio 49.6333
Sharpe -0.9653
Alpha 1.3477
Beta 0.8784
Sortino 0.2785
Minimum Investment Amounts
Minimum for 1st Investment 5000
Minimum for SIP 100
Returns and rankings
Category : Equity
Annualised returns
1Y 3Y 5Y
Fund returns 48.97 18.49 29.88
Category average -9.1 23.3 12.4
Rank with in category 3 3 1
Expense ratio:1.82

Inclusive of GST

Exit load

1% on or before 1M, Nil after 1M

Stamp duty

0.005% (from July 1st, 2020)

Tax implication

Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

Fund house & investment objective
Rank (total assets) ---
Total AUM ₹5,49,998.30Cr
Date of Incorporation ---

Investment Objective

The Primary Investment Objective Of The Scheme Is To Generate Consistent Returns By Investing In Equity / Equity Related Or Fixed Income Securities Of Pharma And Other Associated Companies

Fund benchmark S&P BSE Health Care
Fund house contact details
Address: Reliance Centre, 7th Floor, South Wing, Off Western Express Highway, Santacruz
Mumbai - 400 055
Phone:--------
Launch Date:--------
Nippon Life India Asset Management Limited
Custodian:Deutsche Bank
Registrar & Transfer Agent:Karvy
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
Compare funds
Funds Comparison
Fund management
Sailesh Raj Bhan
Jan 2013 - Present